Acute loss of DP1, but not DP2, induces p53 mRNA and augments p21Waf1/Cip1 and senescence

Cell Biochemistry and Function

Volumn 30, Issue 1, 2012, Pages 54-60

  Ohdaira, Hiroaki ^a   Sekiguchi, Masaki ^a   Miyata, Kenichi ^a   Sasaki, Tomoe ^a   Yoshida, Kenichi ^a  

^a MEIJI UNIVERSITY   (Japan)

Author keywords

Cell cycle; E2F DP; P53; Senescence; Transcriptional regulation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; MESSENGER RNA; PROTEIN BAX; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR DP2; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA BINDING PROTEIN; TFDP2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA MICROARRAY; DNA REPLICATION; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RNA INTERFERENCE; SOMATIC CELL; CELL AGING; GENETICS; METABOLISM; TUMOR CELL LINE;

CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; HUMANS; RNA, MESSENGER; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855299258     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1818     Document Type: Article

References (16)

1. Lazzerini Denchi E, Helin K. The E2F family: specific functions and overlapping interests. EMBO J 2004; 23: 4709-4716.
2. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006; 6: 739-748.
3. Hitchens MR, Robbins PD. The role of the transcription factor DP in apoptosis. Apoptosis 2003; 8: 461-468.
4. Kohn MJ, Leung SW, Criniti V, Agromayor M, Yamasaki L. Dp1 is largely dispensable for embryonic development. Mol Cell Biol 2004; 24: 7197-7205.
5. Qiao H, Di Stefano L, Tian C, et al. Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F. J Biol Chem 2007; 282: 454-466.
6. Sato K, Kusama Y, Tategu M, Yoshida K. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells. Int J Oncol 2010; 36: 479-490.
7. Ohdaira H, Nakagawa H, Yoshida K. Profiling of molecular pathways regulated by microRNA 601. Comput Biol Chem 2009; 33: 429-433.
8. Kusama Y, Sato K, Kimura N, Mitamura J, Ohdaira H, Yoshida K. Comprehensive analysis of expression pattern and promoter regulation of human autophagy-related genes. Apoptosis 2009; 14: 1165-1175.
9. Rogers KT, Higgins PD, Milla MM, Phillips RS, Horowitz JM. DP-2, a heterodimeric partner of E2F: identification and characterization of DP-2 proteins expressed in vivo. Proc Natl Acad Sci USA 1996; 93: 7594-7599.
10. Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer 2009; 9: 738-748.
11. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24: 2899-2908.
12. Maehara K, Yamakoshi K, Ohtani N, et al. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53. J Cell Biol 2005; 168: 553-560.
13. Boggs K, Reisman D. Increased p53 transcription prior to DNA synthesis is regulated through a novel regulatory element within the p53 promoter. Oncogene 2006; 25: 555-565.
14. Wu L, Timmers C, Maiti B, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001; 414: 457-462.
15. Timmers C, Sharma N, Opavsky R, et al. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol Cell Biol 2007; 27: 65-78.
16. Jooss K, Lam EW, Bybee A, Girling R, Müller R, La Thangue NB. Proto-oncogenic properties of the DP family of proteins. Oncogene 1995; 10: 1529-1536.